Baylor University Medical Center in Dallas has launched what they are saying is the nation’s first clinical trial of patients using robotic exoskeletons as part of early mobility after major heart and lung procedures.
According to NBC DFW, the study is known as the REACT trial (Robotic Exoskeletons for Acute Care Therapy) and is examining whether the devices can help critically ill cardiovascular and thoracic surgery patients walk earlier and more often than with traditional methods.
Dr. Dan M. Meyer, chief of cardiac transplantation and advanced cardiac circulatory support at Baylor University Medical Center and the trial’s principal investigator, says the technology could change how patients recover after surgery.
“This research represents a unique intersection of robotics, critical care, and rehabilitation,” he said. “Our goal is to enhance recovery and set a new standard for early mobility after major surgeries.”
LISTEN on the Audacy App
Sign Up and Follow 100.3 JACK-FM
Facebook | Twitter | Instagram
